Publications by authors named "Carmen Tur"

62Publications

In vivo imaging of chronic active lesions in multiple sclerosis.

Mult Scler 2020 Sep 23:1352458520958589. Epub 2020 Sep 23.

Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK/Radiology & Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458520958589DOI Listing
September 2020

Sodium in the Relapsing-Remitting Multiple Sclerosis Spinal Cord: Increased Concentrations and Associations With Microstructural Tissue Anisotropy.

J Magn Reson Imaging 2020 Jun 1. Epub 2020 Jun 1.

NMR Research Unit, Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.27201DOI Listing
June 2020

Translating pH-sensitive PROgressive saturation for QUantifying Exchange rates using Saturation Times (PRO-QUEST) MRI to a 3T clinical scanner.

Magn Reson Med 2020 Oct 28;84(4):1734-1746. Epub 2020 Feb 28.

Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrm.28229DOI Listing
October 2020

Disrupted principal network organisation in multiple sclerosis relates to disability.

Sci Rep 2020 02 27;10(1):3620. Epub 2020 Feb 27.

Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-60611-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046772PMC
February 2020

Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.

Mult Scler 2020 Jan 21:1352458519900971. Epub 2020 Jan 21.

Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Biomedical Research Centre, University College London Hospitals (UCLH), National Institute for Health Research (NIHR), London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519900971DOI Listing
January 2020

The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.

Mult Scler 2019 Oct 15:1352458519877810. Epub 2019 Oct 15.

Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Servei de Neurologia/Neuroimmunologia, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain/Division of Neurology, University of Toronto, St Michael's Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519877810DOI Listing
October 2019

Head-to-head drug comparisons in multiple sclerosis: Urgent action needed.

Neurology 2019 10 7;93(18):793-809. Epub 2019 Oct 7.

From the Department of Neuroinflammation (C.T.), Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, University College London, UK; Neurology/Neuroimmunology Department (C.T., M.T., X.M.), Multiple Sclerosis Centre of Catalonia, Vall d'Hebron University Hospital, Barcelona, Spain; Department of Medicine (T.K.), CORe, University of Melbourne, Australia; Department of Neurology (T.K.), Royal Melbourne Hospital, Australia; Division of Neurology (J.O., X.M.), University of Toronto, St Michael's Hospital, Canada; Department of Health Sciences (DISSAL) (M.P.S.), University of Genoa, Italy; and Central Clinical School (H.B.), Alfred Centre, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000008319DOI Listing
October 2019

Erratum: Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis.

NPJ Digit Med 2019;2:66. Epub 2019 Jul 16.

2Multiple Sclerosis Research Centre, NMR Research Unit, Department of Neuroinflammation, Queen Square Institute of Neurology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41746-019-0144-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635413PMC
July 2019

Single-subject structural cortical networks in clinically isolated syndrome.

Mult Scler 2020 Oct 24;26(11):1392-1401. Epub 2019 Jul 24.

Centre for Medical Image Computing (CMIC), UCL Medical Physics and Biomedical Engineering, University College London, London, UK/NIHR University College London Hospitals Biomedical Research Centre, London, UK/Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands/UCL Institute of Healthcare Engineering and UCL Queen Square Institute of Neurology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519865739DOI Listing
October 2020

High-dimensional detection of imaging response to treatment in multiple sclerosis.

NPJ Digit Med 2019 10;2:49. Epub 2019 Jun 10.

2Multiple Sclerosis Research Centre, NMR Research Unit, Department of Neuroinflammation, Queen Square Institute of Neurology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41746-019-0127-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556513PMC
June 2019

A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis.

Mult Scler 2020 06 10;26(7):774-785. Epub 2019 May 10.

Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK/National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519845105DOI Listing
June 2020

Clinical relevance of cortical network dynamics in early primary progressive MS.

Mult Scler 2020 04 25;26(4):442-456. Epub 2019 Feb 25.

Queen Square MS Centre, UCL Institute of Neurology, University College London (UCL), London, UK/National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519831400DOI Listing
April 2020

Structural network disruption markers explain disability in multiple sclerosis.

J Neurol Neurosurg Psychiatry 2019 02 22;90(2):219-226. Epub 2018 Nov 22.

Department of Neuroinflammation, UCL Institute of Neurology, Queen Square MS Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2018-318440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518973PMC
February 2019

Relevance of time-dependence for clinically viable diffusion imaging of the spinal cord.

Magn Reson Med 2019 02 5;81(2):1247-1264. Epub 2018 Sep 5.

Queen Square MS Centre, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrm.27463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586052PMC
February 2019

Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.

Neurology 2018 09 17;91(12):e1130-e1134. Epub 2018 Aug 17.

From the Queen Square Multiple Sclerosis Centre (W.J.B., C.T., D.H.M., O.C.), Department of Neuroinflammation, UCL Institute of Neurology; Lysholm Department of Neuroradiology (K.A.M., F.B.), National Hospital for Neurology and Neurosurgery; UCL Institute of Healthcare Engineering (F.B.), London, UK; Department of Radiology and Nuclear Medicine (F.B.), VU University Medical Centre, Amsterdam, the Netherlands; and NIHR University College London Hospitals Biomedical Research Centre (F.B., O.C.), UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161554PMC
September 2018

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.

Neurology 2018 04 7;90(14):e1183-e1190. Epub 2018 Mar 7.

From the NMR Research Unit (R.C., L.M., C.T., F.D., M.C.Y., F.P., F.B., O.C.), Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London; NMO Clinical Service at the Walton Centre (K.A.-A., A.J.), Liverpool; Translational Imaging Group (F.P., S.O., F.B.), Centre for Medical Image Computing (CMIC), Department of Medical Physics and Bioengineering, University College London; Lysholm Department of Neuroradiology (T.A.Y.), National Hospital for Neurology and Neurosurgery, London, UK; Department of Radiology and Nuclear Medicine (F.B.), MS Centre Amsterdam, VU Medical Centre Amsterdam, the Netherlands; and National Institute for Health Research (NIHR) (T.A.Y., F.B., O.C.), University College London Hospitals (UCLH) Biomedical Research Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005256DOI Listing
April 2018

Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Mult Scler Relat Disord 2018 01 12;19:168-170. Epub 2016 Aug 12.

Queen Square MS Centre NMR Research Unit, Department of Neuroinflammation, UCL Institute of Neurology, London, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.08.006DOI Listing
January 2018

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Nat Rev Neurol 2018 02 12;14(2):75-93. Epub 2018 Jan 12.

Queen Square Multiple Sclerosis Centre, University College of London Institute of Neurology, London WC1B 5EH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2017.171DOI Listing
February 2018

Progressive MS trials: Lessons learned.

Mult Scler 2017 Oct;23(12):1583-1592

Department of Neurology-Neuroimmunology and Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517729460DOI Listing
October 2017

Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?

Ann Clin Transl Neurol 2017 09 15;4(9):663-679. Epub 2017 Aug 15.

NMR Research Unit Department of Neuroinflammation Queen Square MS Centre UCL Institute of Neurology University College London London United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590517PMC
September 2017

Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

JAMA Neurol 2017 08;74(8):970-976

Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2017.1125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710320PMC
August 2017

Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.

Mult Scler 2018 06 18;24(7):932-941. Epub 2017 May 18.

Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London (UCL), London, UK/UCL Hospitals Biomedical Research Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517709954DOI Listing
June 2018

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

Mult Scler 2018 05 26;24(6):721-727. Epub 2017 Apr 26.

Department of Neurology-Neuroimmunology and Multiple Sclerosis Centre of Catalonia (Cemcat), Edifici Cemcat, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517707070DOI Listing
May 2018

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor.

Mult Scler 2018 03 16;24(3):301-312. Epub 2017 Mar 16.

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458517697830
Publisher Site
http://dx.doi.org/10.1177/1352458517697830DOI Listing
March 2018

Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients.

Mult Scler 2018 03 13;24(3):322-330. Epub 2017 Mar 13.

Servicio de Neurologia-Neuroimmunolgia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458517698052
Publisher Site
http://dx.doi.org/10.1177/1352458517698052DOI Listing
March 2018

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis.

Neurology 2016 Sep 26;87(13):1368-74. Epub 2016 Aug 26.

From Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Department of Neurology/Neuroimmunology (M.T., S.O.-R., J.R., G.A., B.P., C.T., I.G., M.C., C.N., M.J.A., A.V.-J., J.C., B.R.-A., L.M., J.S.-G., X.M.), and Magnetic Resonance Unit, Department of Radiology (R.M., C.A., À.R.), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003144DOI Listing
September 2016

Neurofilament light chain level is a weak risk factor for the development of MS.

Neurology 2016 Sep 12;87(11):1076-84. Epub 2016 Aug 12.

From Servei de Neurologia-Neuroimmunologia (G.A., C.E., H.E., J.S.-G., E.S., M.C., J.R., C.N., C.T., J.C., A.V.-J., I.G., M.J.A., X.M., M.T.), Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona; Universitat Autònoma de Barcelona (G.A., C.E., H.E., J.S.-G., E.S., M.C., J.R., C.N., C.T., J.C., A.V.-J., I.G., X.M., M.T.), Bellaterra; Departments of Neurology and Immunology (L.M.V., J.C.A.-C., C.P.), Multiple Sclerosis Unit, Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Neurology (J.K., L.K.), University Hospital Basel; Neurocentre of Southern Switzerland (G.D.), Ospedale Civico, Lugano, Switzerland; and Magnetic Resonance Unit (IDI) (D.P., C.A., A.R.), Hospital Universitari Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027802PMC
September 2016

Grey matter atrophy is associated with disability increase in natalizumab-treated patients.

Mult Scler 2017 Apr 11;23(4):556-566. Epub 2016 Jul 11.

Servei de Neurologia/Neuroimmunologia, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516656808DOI Listing
April 2017

HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Mult Scler Relat Disord 2016 May 7;7:47-52. Epub 2016 Mar 7.

Queen Square MS Centre NMR Research Unit, Department of Neuroinflammation, UCL Institute of Neurology, London, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.03.003DOI Listing
May 2016

Fatigue Management in Multiple Sclerosis.

Authors:
Carmen Tur

Curr Treat Options Neurol 2016 Jun;18(6):26

National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11940-016-0411-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834309PMC
June 2016

Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis.

Neuroimage Clin 2016 10;10:71-7. Epub 2015 Nov 10.

NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK; Brain Connectivity Center, C. Mondino National Neurological Institute, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nicl.2015.11.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678307PMC
October 2016

Early accurate diagnosis crucial in multiple sclerosis.

Practitioner 2015 Sep;259(1785):21-7, 2-3

View Article

Download full-text PDF

Source
September 2015

Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?

Mult Scler 2015 Dec 10;21(14):1876-8. Epub 2015 Sep 10.

Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458515604746DOI Listing
December 2015

Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.

Brain 2015 Sep;138(Pt 9):2584-95

1 NMR Research Unit, Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, UK 7 National Institute of Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC), London, UK.

View Article

Download full-text PDF

Source
http://brain.oxfordjournals.org/content/brain/138/9/2584.ful
Web Search
http://www.brain.oxfordjournals.org/lookup/doi/10.1093/brain
Publisher Site
http://dx.doi.org/10.1093/brain/awv209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643627PMC
September 2015

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Nat Rev Neurol 2015 08 7;11(8):471-82. Epub 2015 Jul 7.

Magnetic Resonance Unit, Cemcat, Hospital Vall d'Hebron, Autonomous University of Barcelona, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2015.106DOI Listing
August 2015

Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.

Mult Scler 2015 Jul 26;21(8):1084-6. Epub 2015 May 26.

Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458515586090DOI Listing
July 2015

Defining high, medium and low impact prognostic factors for developing multiple sclerosis.

Brain 2015 Jul 21;138(Pt 7):1863-74. Epub 2015 Apr 21.

1 Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awv105DOI Listing
July 2015

Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

Mult Scler 2015 Apr 6;21(5):660-1. Epub 2015 Feb 6.

Multiple Sclerosis Centre of Catalonia Neurology/Neuroimmunology Department Vall d'Hebron University Hospital Barcelona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514551457DOI Listing
April 2015

HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.

Neurology 2014 Nov 8;83(19):1712-8. Epub 2014 Oct 8.

From the Departments of Brain Repair and Rehabilitation (C.T., B.B., Z.K., A.J.T., O.C.) and Neuroinflammation (D.R.A., D.H.M.), University College of London Institute of Neurology, UK; Multiple Sclerosis Centre of Catalonia (Cemcat) (C.T.), Neurology-Neuroimmunology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Blizard Institute (S.R.), Queen Mary University of London; Medical Statistics Department (D.R.A.), London School of Hygiene and Tropical Medicine, University of London; Clinical Imaging Sciences Centre (M.C.), Brighton and Sussex Medical School, Falmer, East Sussex; and National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, UK.

View Article

Download full-text PDF

Source
http://www.neurology.org/content/83/19/1712.full.pdf
Web Search
http://www.neurology.org/cgi/doi/10.1212/WNL.000000000000095
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000000959DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239831PMC
November 2014

NMO spectrum disorders: how wide is the spectrum?

Mult Scler 2014 Sep;20(10):1417-9

Centre d'Esclerosi Múltiple de Catalunya (Cemcat)/Neuroimmunology, Hospital Universitari Vall d'Hebron; Universitat Autònoma de Barcelona, Barcelona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514546517DOI Listing
September 2014

Secondary progression is not the only explanation.

Acta Med Port 2014 May-Jun;27(3):393-6. Epub 2014 Jun 30.

Neurology-Neuroimmunology Department. Multiple Sclerosis Centre of Catalonia. Vall d'Hebron University Hospital. Barcelona. Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20344/amp.4322DOI Listing
March 2016

Natalizumab: risk stratification of individual patients with multiple sclerosis.

CNS Drugs 2014 Jul;28(7):641-8

Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, Barcelona, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-014-0168-0DOI Listing
July 2014

Understanding the role of gender and hormones in multiple sclerosis.

Mult Scler 2014 Apr;20(5):518-9

MS Centre of Catalonia (Cemcat), Neurology/Neuroimmunology Department, Vall d'Hebron University Hospital, Pg. Vall d'Hebron 119-129, Barcelona, 08035, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514528266DOI Listing
April 2014

Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.

Mult Scler 2014 Oct 12;20(12):1602-8. Epub 2014 Mar 12.

Centre d'esclerosi múltiple de Catalunya (CEM-Cat), Servei de Neurologia-Neuroimmunologia, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514527863DOI Listing
October 2014

Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.

Mult Scler 2014 Apr 27;20(4):510-1. Epub 2014 Jan 27.

Multiple Sclerosis Centre of Catalonia, Neurology/Neuroimmunology Department, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513517281DOI Listing
April 2014

CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: No.

Mult Scler 2013 May;19(6):717-8

Multiple Sclerosis Centre of Catalonia, Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513477713DOI Listing
May 2013

Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.

Hum Brain Mapp 2014 Mar 26;35(3):993-1003. Epub 2012 Dec 26.

Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, United Kingdom; Department of Medicine, Clinical Neuroimmunology Unit, Multiple Sclerosis Centre of Catalonia (CEM-Cat), Autonomous University of Barcelona, CARM-Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hbm.22229
Publisher Site
http://dx.doi.org/10.1002/hbm.22229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238834PMC
March 2014

Subcutaneous alemtuzumab for multiple sclerosis.

Expert Rev Clin Immunol 2012 Jul;8(5):423-6

Clinical Neuroimmunology Unit, Multiple Sclerosis Centre of Catalonia (CEM-Cat), Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.12.30DOI Listing
July 2012

[Disease modifying drugs in multiple sclerosis and pregnancy].

Med Clin (Barc) 2012 Sep 27;139(7):316-8. Epub 2012 Jun 27.

Centre d'Esclerosi Múltiple de Catalunya (CEM-Cat), Unitat de Neuroimmunologia Clínica, Servei de Neurologia, Hospital Vall d'Hebron, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2012.04.021DOI Listing
September 2012

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.

Mult Scler 2012 Aug 1;18(8):1193-6. Epub 2012 Mar 1.

Clinical Neuroimmunology Unit, Multiple Sclerosis Centre of Catalonia (Centre d'Esclerosi Múltiple de Catalunya, CEM-Cat), Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458512439238DOI Listing
August 2012

Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

Arch Neurol 2011 Nov;68(11):1421-7

Multiple Sclerosis Centre of Catalonia, Autonomous University of Barcelona, Centre d'Anàlisi i Recerca en Neuroimatge i Esclerosi Mùltiple-Vall d'Hebron University Hospital, Escola Universitària d'Infermeria 2ª Planta, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://archneur.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archneurol.2011.241DOI Listing
November 2011